It’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and 21 flatlining.

 

Here’s a table showing how ASX-listed healthcare stocks have been performing.

CODE COMPANY PRICE 1 WEEK RETURN % 6 MONTH RETURN % 1 YEAR RETURN % MARKET CAP
ADO Anteotech Ltd 0.23 31.4% 17.9% 109.1% $394,808,878
AT1 Atomo Diagnostics 0.195 18.2% -9.3% -35.0% $71,520,809
AVE Avecho Biotech Ltd 0.015 15.4% -11.8% -16.7% $27,541,748
GSS Genetic Signatures 1.425 14.0% 9.0% -13.6% $191,748,970
PTX Prescient Ltd 0.225 12.5% -4.3% 240.9% $152,771,903
BIT Biotron Limited 0.091 11.0% 85.7% 16.7% $63,173,944
VBS Vectus Biosystems 1.3 10.2% -10.3% 15.0% $42,311,684
PGC Paragon Care Limited 0.325 8.3% 12.1% 47.7% $114,205,227
BOT Botanix Pharma Ltd 0.058 7.4% -3.3% -53.6% $57,415,382
SHG Singular Health 0.295 7.3% 11.3% 0.0% $18,761,110
EZZ EZZ Life Science 0.525 7.1% 11.7% 0.0% $6,507,600
ZNO Zoono Group Ltd 0.395 6.8% -3.7% -69.8% $61,992,265
IHL Incannex Healthcare 0.535 5.9% -2.7% 269.0% $610,306,642
BWX BWX Limited 4.5 5.9% 0.7% 10.3% $691,818,929
CAJ Capitol Health 0.365 5.8% -1.4% 30.4% $380,409,392
DVL Dorsavi Ltd 0.019 5.6% -13.6% -50.0% $6,723,744
RGS Regeneus Ltd 0.077 5.5% 10.0% -43.0% $22,982,769
VTI Vision Tech Inc 0.9 5.3% -4.3% -62.5% $21,981,015
NYR Nyrada Inc. 0.215 4.9% -10.4% -6.5% $27,038,626
IIQ Inoviq Ltd 1.075 4.9% -4.4% 64.1% $98,920,105
PXS Pharmaxis Ltd 0.11 4.8% 0.0% 29.4% $57,492,678
RNO Rhinomed Ltd 0.27 3.8% 12.5% 54.3% $74,045,603
AHC Austco Healthcare 0.145 3.6% 3.6% 45.0% $39,786,453
MDC Medlab Clinical Ltd 0.145 3.6% -14.7% -42.0% $49,615,472
MVP Medical Developments 5.235 3.5% 6.8% -21.6% $369,230,695
NXS Next Science Limited 1.22 3.4% 0.0% -6.2% $241,528,169
DOC Doctor Care Anywhere 0.46 3.4% -14.8% -61.7% $82,739,800
PBP Probiotec Limited 2.22 3.3% 6.7% -1.3% $180,537,961
VLS Vita Life Sciences.. 1.93 3.2% 12.2% 93.0% $101,619,541
HXL Hexima 0.37 2.8% 8.8% 111.4% $58,573,650
IVX Invion Ltd 0.0185 2.8% -11.9% 85.0% $121,913,759
ANP Antisense Therapeut. 0.185 2.8% -11.9% 42.3% $124,983,838
RCE Recce Pharmaceutical 0.97 2.6% 13.5% -7.6% $166,836,333
PSQ Pacific Smiles Grp 2.77 2.6% -7.0% 10.8% $426,083,774
1AD Adalta Limited 0.082 2.2% -4.8% -28.0% $24,949,244
PAA Pharmaust Limited 0.092 2.2% -8.0% -12.4% $28,839,027
CYP Cynata Therapeutics 0.47 2.2% -8.7% -31.9% $64,474,467
PCK Painchek Ltd 0.053 1.9% 6.0% -33.8% $57,722,045
CAN Cann Group Ltd 0.29 1.8% -3.3% -41.4% $99,423,533
CBL Control Bionics 0.425 1.2% -5.6% -57.5% $20,132,362
OPT Opthea Limited 1.28 0.4% 5.8% -33.7% $446,962,886
ALT Analytica Limited 0.002 0.0% 33.3% 0.0% $6,920,702
ONE Oneview Healthcare 0.25 0.0% -9.1% 455.6% $129,100,328
BDX Bcaldiagnostics 0.13 0.0% -16.1% 0.0% $17,098,453
SCU Stemcell United Ltd 0.014 0.0% 0.0% -12.5% $14,606,489
IPD Impedimed Limited 0.17 0.0% -5.6% 30.8% $293,009,063
ICS ICSGlobal Limited 0.575313 0.0% 0.0% 6.8% $6,054,605
FFC Farmaforce Ltd 0.046 0.0% -16.4% -45.9% $6,011,325
AN1 Anagenics Limited 0.056 0.0% -8.2% -42.7% $12,332,177
AHK Ark Mines Limited 0.034 0.0% 0.0% 0.0% $88,944
CTE Cryosite Limited 0.405 0.0% 12.5% 11.0% $19,767,873
PYC PYC Therapeutics 0.14 0.0% -6.7% 0.0% $445,329,654
RAD Radiopharm 0.37 0.0% 0.0% 0.0% $43,166,784
RAD Radiopharm 0.37 0.0% 0.0% 0.0% $43,166,784
LBT LBT Innovations 0.097 0.0% 2.1% -15.7% $28,044,171
TD1 Tali Digital Limited 0.02 0.0% -13.0% -56.5% $17,240,257
1ST 1St Group Ltd 0.013 0.0% -7.1% -59.5% $6,549,087
IMC Immuron Limited 0.11 0.0% -12.0% -54.2% $26,196,810
GTG Genetic Technologies 0.0055 0.0% -8.3% -21.4% $46,169,826
S66 Star Combo 0.255 0.0% -8.9% -27.1% $34,298,260
BPH BPH Energy Ltd 0.037 0.0% -15.9% 5.7% $24,602,017
PAL Palla Pharma Ltd 0.295 0.0% -25.3% -59.4% $47,764,383
ACR Acrux Limited 0.0995 -0.5% -17.1% -43.1% $28,368,034
CMP Compumedics Limited 0.3925 -0.6% 12.1% -13.7% $69,093,550
TLX Telix Pharmaceutical 7.83 -0.9% 9.7% 99.2% $2,306,239,826
NC6 Nanollose Limited 0.099 -1.0% -13.9% 90.4% $14,888,637
IMM Immutep Ltd 0.48 -1.0% -11.1% 23.1% $409,978,944
PAR Paradigm Bio. 1.92 -1.3% -10.7% -23.2% $430,156,053
PIQ Proteomics Int Lab 1.115 -1.3% 16.1% 36.0% $119,391,139
IBX Imagion Biosys Ltd 0.072 -1.4% -17.2% -42.4% $80,713,334
MVF Monash IVF Group Ltd 0.985 -1.5% 5.9% 25.5% $385,738,492
UBI Universal Biosensors 0.88 -1.7% -5.4% 125.6% $156,489,084
CHM Chimeric Therapeutic 0.26 -1.9% -10.3% 0.0% $57,298,102
SDI SDI Limited 1 -2.0% -6.5% 24.2% $119,459,858
KZA Kazia Therapeutics 1.105 -2.2% -27.8% -5.6% $143,920,558
ARX Aroa Biosurgery 1.0175 -2.6% -11.5% -7.5% $350,853,536
NOX Noxopharm Limited 0.365 -2.7% -24.0% -18.9% $99,360,903
PAB Patrys Limited 0.036 -2.7% -14.3% 72.2% $71,985,288
ALA Arovella Therapeutic 0.036 -2.7% -18.2% 0.0% $17,313,152
MDR Medadvisor Limited 0.355 -2.7% -6.6% -5.3% $143,587,400
ATX Amplia Therapeutics 0.17 -2.9% -15.0% -25.3% $30,043,476
ZLD Zelira Therapeutics 0.032 -3.0% -17.9% -64.4% $38,286,949
SOM SomnoMed Limited 2.13 -3.2% -7.8% 2.4% $176,277,341
CU6 Clarity Pharma 0.715 -3.4% -24.7% 0.0% $116,643,365
RSH Respiri Limited 0.057 -3.4% -3.4% -52.5% $41,201,925
PNV Polynovo Limited 1.515 -3.5% 4.8% -61.2% $955,705,724
ILA Island Pharma 0.26 -3.7% -7.1% 0.0% $11,243,223
ACW Actinogen Medical 0.13 -3.7% -23.5% 584.2% $230,730,057
CDX Cardiex Limited 0.05 -3.8% -12.3% -3.8% $54,951,126
ALC Alcidion Group Ltd 0.25 -3.8% -27.2% 41.6% $317,659,197
HCT Holista CollTech Ltd 0.048 -4.0% -11.1% -31.4% $13,216,756
CGS Cogstate Ltd 2.3 -4.2% -0.9% 101.8% $396,983,827
BNO Bionomics Limited 0.115 -4.2% -4.2% -17.0% $157,146,809
DXB Dimerix Ltd 0.23 -4.2% -14.8% 27.8% $73,800,943
ATH Alterity Therap Ltd 0.022 -4.3% -15.4% -29.0% $52,951,241
OSX Osteopore Limited 0.22 -4.3% -2.2% -56.4% $26,971,695
RAC Race Oncology Ltd 3.27 -4.4% -3.3% 89.0% $515,006,646
JTL Jayex Technology Ltd 0.021 -4.5% -8.7% -50.0% $5,233,799
AC8 Auscann Grp Hlgs Ltd 0.082 -4.7% -21.9% -50.3% $36,565,410
4DX 4Dmedical Limited 1.23 -4.7% 3.8% -45.6% $254,926,031
MX1 Micro-X Limited 0.255 -4.7% -19.0% -29.2% $119,633,214
CYC Cyclopharm Limited 1.59 -4.8% -14.3% -36.4% $148,932,843
OSP Osprey Med Inc 0.565 -5.0% -29.8% -71.8% $14,368,784
MXC Mgc Pharmaceuticals 0.037 -5.1% -19.6% 54.2% $99,847,053
NEU Neuren Pharmaceut. 3.61 -5.2% 93.0% 182.0% $487,487,166
OIL Optiscan Imaging 0.18 -5.3% -10.0% 56.5% $111,453,408
TRU Truscreen 0.07 -5.4% -11.4% 0.0% $25,400,638
M7T Mach7 Tech Limited 0.82 -5.7% -7.9% -32.2% $196,947,422
MEM Memphasys Ltd 0.092 -6.1% -12.4% -34.3% $74,464,764
NSB Neuroscientific 0.305 -6.2% -14.1% 17.3% $43,758,851
TRP Tissue Repair 0.525 -6.3% -18.6% 0.0% $21,074,858
RAP Resapp Health Ltd 0.058 -6.5% 5.5% -30.1% $51,551,825
GLH Global Health Ltd 0.345 -6.8% -9.2% -20.7% $21,511,569
OSL Oncosil Medical 0.038 -7.3% -19.1% -69.6% $30,109,045
OCC Orthocell Limited 0.5 -7.4% -3.8% 22.0% $96,639,165
EXL Elixinol Wellness 0.073 -7.6% -25.5% -59.4% $23,693,338
VHT Volpara Health Tech 0.99 -7.9% -7.0% -25.3% $247,689,165
ICR Intelicare Holdings 0.081 -8.0% -8.0% -66.0% $3,816,844
ADR Adherium Ltd 0.011 -8.3% -8.3% -52.2% $24,240,365
LCT Living Cell Tech. 0.0055 -8.3% -31.3% -58.9% $4,916,028
AGH Althea Group 0.215 -8.5% -20.4% -48.2% $67,172,670
MMJ MMJ Group Hlds Ltd 0.059 -9.2% -15.7% -50.8% $13,107,377
IRX Inhalerx Limited 0.077 -9.4% -23.0% -3.8% $12,971,956
TSN The Sust Nutri Grp 0.22 -10.2% -6.4% -36.2% $21,848,937
EPN Epsilon Healthcare 0.079 -10.2% -28.2% -68.4% $16,703,021
BXN Bioxyne Ltd 0.026 -10.3% 8.3% 116.7% $16,643,780
LDX Lumos Diagnostics 0.68 -10.5% -20.0% 0.0% $103,794,623
CPH Creso Pharma Ltd 0.079 -11.2% -21.0% -58.4% $93,203,383
NTI Neurotech Intl 0.053 -11.7% -20.9% 35.9% $36,952,402
AMT Allegra Orthopaedics 0.15 -11.8% -23.1% -59.5% $15,668,880
RHT Resonance Health 0.1 -13.0% -4.8% -54.5% $46,085,198
OVN Oventus Medical Ltd 0.08 -13.0% -17.5% -61.0% $19,338,123
RHY Rhythm Biosciences 1.48 -14.5% -21.3% 81.0% $309,238,997
EYE Nova EYE Medical Ltd 0.305 -15.3% -20.8% -9.0% $44,393,906
IMU Imugene Limited 0.41 -15.5% -27.4% 327.1% $2,419,148,071
MEB Medibio Limited 0.005 -28.6% -28.6% -37.5% $10,305,256
IDT IDT Australia Ltd 0.28 -41.7% -34.9% 64.7% $69,559,449
ONT 1300 Smiles Limited 0 -100.0% -100.0% -100.0% $168,827,115

 

The biggest winner this fortnight was Anteotech (ASX:ADO). 

Shares are up 31.4% on news of a $1.96m refund under the Federal Government’s Research & Development Tax Incentive scheme.

The rebate relates to R&D activities conducted by AnteoTech in both its Life Science and Energy divisions for the 2021 financial year.

ADO says funds will be reinvested into the continued development of its lateral flow test product offerings for the EuGeni platform and the AnteoX program, which is targeting electrode coating cohesion of lithium-ion battery electrodes.

The EuGeni platform is Anteoch’s compact solution for rapid point-of-care testing – it is a highly interactive, user-friendly reader system underpinned by patented AnteoBind™ nanoparticle technology and can be easily transported into clinics.

Atomo Diagnostics (ASX:AT1) was up 18.2% on no news while Avecho Biotech (ASX:AVE) gained 15.4% after securing a product licence and supply agreement with Medterra Pharma for its CBD soft-gel capsule for the oral treatment of arthritis.

Medterra is one of the most successful CBD companies in the United States and plans to develop AVE’s product with the intent to support FDA approval.

Avecho said this marked a “strategic step forward” in its ambitions to secure Food and Drug Administration approval for its soft-gel CBD product, which will occur in parallel to existing work to register the product for sleep indications with the Therapeutic Goods Administration.

Up 14% was Genetic Signatures (ASX:GSS) with a forecast revenue projection of $21m targeted for the first quarter of 2022.

Prescient Therapeutics (ASX:PTX) was up 12.5% on no news and Biotron (ASX:BIT) saw an 11% rise following an update to market on an extension to its phase-2 HIV-1 trial.

The trial incorporates PTX’s antiviral drug BIT225 and the extension includes a second Australian site – St Vincent’s Hospital Human Research Ethics Committee has approved the study and will be bringing on board a second key trial site at St Vincent’s Hospital in Sydney.

 

Who flatlined?

Amongst the 21 flatliners was Star Combo (ASX:S66), Tali Digital (ASX:TD1), and PYC Therapeutics (ASX:PYC).

Another flatliner was Anagenics (ASX:AN1), formerly named Cellmid.

AN1 said the inspiration for the recent name change traces back to the Greek word for regeneration, anagennisi, and reflects the company’s story, business, and future aspirations.

 

Who’s the biggest loser?

The biggest dipper was IDT Australia (ASX:IDT).

Its shares dropped 41.7% in the past fortnight when news broke out that IDT’s ATM submission had not been selected to progress to the next stage.

The Australian Government announced that a new manufacturing facility will be built in Australia in collaboration with Moderna to produce respiratory mRNA vaccines in the onshore mRNA Approach To Market process.

IDT is now liaising directly with the Australian and Victorian governments to better understand their approach to supporting Australia’s mRNA translation and manufacturing ecosystem.

The second biggest loser was Medibio (ASX:MEB) with shares down 28.6% and Imugene (ASX:IMU) came third at 15.5%.